Correction to: Consumption of Synbiotic Bread Decreases Triacylglycerol and VLDL Levels While Increasing HDL Levels in Serum from Patients with Type-2 Diabetes (Lipids, (2014), 49, 7, (695-701), 10.1007/s11745-014-3901-z);Consumption of synbiotic bread decreases triacylglycerol and VLDL levels while increasing HDL levels in serum from patients with type-2 diabetes

Lipids

Volumn 49, Issue 7, 2014, Pages 695-701

  Shakeri, Hossein ^a   Hadaegh, Haleh ^b   Abedi, Fatemeh ^a   Tajabadi Ebrahimi, Maryam ^c   Mazroii, Navid ^a   Ghandi, Yaser ^a   Asemi, Zatollah ^a  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Sahar Bread Company   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Lipid profiles; Probiotic; Synbiotic; Type 2 diabetes mellitus

Indexed keywords

HIGH DENSITY LIPOPROTEIN; INULIN; PROBIOTIC AGENT; SYNBIOTIC AGENT; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BREAD; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; INSULIN TREATMENT; LACTOBACILLUS; LACTOBACILLUS SPOROGENES; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; BLOOD; DIET; DOUBLE BLIND PROCEDURE;

LACTOBACILLUS SPOROGENES;

BREAD; DIABETES MELLITUS, TYPE 2; DIET; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; SYNBIOTICS; TRIGLYCERIDES;

EID: 84903821583     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1002/lipd.12379     Document Type: Erratum

References (32)

1. American Diabetes Association (2014) Diagnosis and classification of diabetes mellitus. Diabetes Care 37(Suppl 1):S81-S90
2. Ruggiero L, Castillo A, Quinn L, Hochwert M (2012) Translation of the diabetes prevention program's lifestyle intervention: role of community health workers. Curr Diab Rep 12:127-137
3. Haghdoost AA, Rezazadeh-Kermani M, Sadghirad B, Baradaran HR (2009) Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis. East Mediterr Health J 15:591-599
4. Johnson M, Krosnick A, Carson P, McDade AM, Laraway K (1998) A retrospective chart review of uncontrolled use of met-formin as an add-on therapy in type 2 diabetes. Clin Ther 20:691-698 (Pubitemid 28421490)
5. Krentz AJ (2003) Lipoprotein abnormalities and their consequences for patients with type 2 diabetes. Diabetes Obes Metab 5(Suppl 1):S19-S27
6. Arca M, Pigna G, Favoccia C (2012) Mechanisms of diabetic dyslipidemia: relevance for atherogenesis. Curr Vasc Pharmacol 10:684-686
7. Yamashita T, Makino H, Nakatani R, Ohata Y, Miyamoto Y, Kishimoto I (2013) Renal insufficiency without albuminuria is associated with peripheral artery atherosclerosis and lipid metabolism disorders in patients with type 2 diabetes. J Atheroscler Thromb 20:790-797
8. Juanola-Falgarona M, Ibarrola-Jurado N, Salas-Salvado J, Rabassa-Soler A, Bullo M (2013) Design and methods of the GLYNDIET study; assessing the role of glycemic index on weight loss and metabolic risk markers. Nutr Hosp 28:382-390
9. Ajala O, English P, Pinkney J (2013) Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr 97:505-516
10. Masana L (2013) Pitavastatin in cardiometabolic disease: therapeutic profile. Cardiovasc Diabetol 12(Suppl 1):S2
11. Farvid MS, Siassi F, Jalali M, Hosseini M, Saadat N (2004) The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes. Diabetes Res Clin Pract 65:21-28 (Pubitemid 38649045)
12. Worthley DL, Le Leu RK, Whitehall VL, Conlon M, Christophersen C, Belobrajdic D et al (2009) A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr 90:578-586
13. Ndagijimana M, Laghi L, Vitali B, Placucci G, Brigidi P, Guerzoni ME (2009) Effect of a synbiotic food consumption on human gut metabolic profiles evaluated by (1)H nuclear magnetic resonance spectroscopy. Int J Food Microbiol 134:147-153
14. Taghizadeh M, Hashemi T, Shakeri H, Abedi F, Sabihi SS, Alizadeh SA et al (2014) Synbiotic food consumption reduces levels of triacylglycerols and VLDL, but not cholesterol, LDL, or HDL in plasma from pregnant women. Lipids 49:155-161
15. Liong MT, Dunshea FR, Shah NP (2007) Effects of a synbiotic containing Lactobacillus acidophilus ATCC 4962 on plasma lipid profiles and morphology of erythrocytes in hypercholesterolaemic pigs on high- and low-fat diets. Br J Nutr 98:736-744 (Pubitemid 47487940)
16. Pereira DI, Gibson GR (2002) Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol 37:259-281 (Pubitemid 35013422)
17. Vitali B, Ndagijimana M, Maccaferri S, Biagi E, Guerzoni ME, Brigidi P (2012) An in vitro evaluation of the effect of probiotics and prebiotics on the metabolic profile of human microbiota. Anaerobe 18:386-391
18. Lin MY, Chang FJ (2000) Antioxidative effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356. Dig Dis Sci 45:1617-1622
19. Lambert JM, Bongers RS, de Vos WM, Kleerebezem M (2008) Functional analysis of four bile salt hydrolase and penicillin acylase family members in Lactobacillus plantarum WCFS1. Appl Environ Microbiol 74:4719-4726
20. Lye HS, Rusul G, Liong MT (2010) Removal of cholesterol by lactobacilli via incorporation and conversion to coprostanol. J Dairy Sci 93:1383-1392
21. Asemi Z, Khorrami-Rad A, Alizadeh SA, Shakeri H, Esmaillzadeh A (2014) Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized crossover controlled clinical trial. Clin Nutr 33:198-203
22. American Diabetes Association (2012) Diagnosis and classification of diabetes mellitus. Diabetes Care 35 Suppl 1:S64-S71
23. Endres JR, Clewell A, Jade KA, Farber T, Hauswirth J, Schauss AG (2009) Safety assessment of a proprietary preparation of a novel probiotic, Bacillus coagulans, as a food ingredient. Food Chem Toxicol 47:1231-1238
24. Asemi Z, Samimi M, Tabasi Z, Talebian P, Azarbad Z, Hydarzadeh Z et al (2012) Effect of daily consumption of probiotic yoghurt on lipid profiles in pregnant women: a randomized controlled clinical trial. J Matern Fetal Neonatal Med 25:1552-1556
25. Russo F, Riezzo G, Chiloiro M, De Michele G, Chimienti G, Marconi E et al (2010) Metabolic effects of a diet with inulinenriched pasta in healthy young volunteers. Curr Pharm Des 16:825-831
26. St-Onge MP, Farnworth ER, Savard T, Chabot D, Mafu A, Jones PJ (2002) Kefir consumption does not alter plasma lipid levels or cholesterol fractional synthesis rates relative to milk in hyperlipidemic men: a randomized controlled trial [ISRCTN10820810]. BMC Complement Altern Med 2:1
27. Savard P, Lamarche B, Paradis ME, Thiboutot H, Laurin E, Roy D (2011) Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults. Int J Food Microbiol 149:50-57
28. Trautwein EA, Rieckhoff D, Erbersdobler HF (1998) Dietary inulin lowers plasma cholesterol and triacylglycerol and alters biliary bile acid profile in hamsters. J Nutr 128:1937-1943 (Pubitemid 28509858)
29. Williams CM (1999) Effects of inulin on lipid parameters in humans. J Nutr 129:1471S-1473S
30. Delzenne NM, Kok N (2001) Effects of fructans-type prebiotics on lipid metabolism. Am J Clin Nutr 73:456S-458S (Pubitemid 32113270)
31. Konstantinov SR, Smidt H, de Vos WM, Bruijns SC, Singh SK, Valence F et al (2008) S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci USA 105:19474-19479
32. Ouwehand AC, Tiihonen K, Saarinen M, Putaala H, Rautonen N (2009) Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters. Br J Nutr 101:367-375